Brief: Akoya Biosciences Q4 Revenue USD 26.5 Million Vs. IBES Estimate USD 25.9 Million
04/03/2024 21:05
Mar 04 (Reuters) - Akoya Biosciences Q4 gross margin 62.7%. * outlook FY revenue USD 114-118 million
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks